THE TGA has designated Baxter’s
inhibitor) as an orphan drug, for
chronic augmentation and
maintenance therapy in adults with
emphysema due to congenital
deficiency of alpha-1-antitrypsin.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 23 Jul 12 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Jul 12
THE Pharmacy Guild of Australia’s approach to politics is “non-partisan and focused on aligning the mutual interests of its community pharmacy members with those of the government, which is tasked with representing the interests of consumers,” says Guild executive director David Quilty writing in Forefront this week.
CHANGES to Australia’s Data Breach Notification Laws which became effective last month have significant implications for Australian pharmacy businesses, according to Giuseppe Carollo from pharmacy insurance specialist Carollo Horton.